Prognostic Power and Therapeutic Precision in Lymphoma and Lung Cancer Management

Categories: Oncology
Wishlist Share
Share Course
Page Link
Share On Social Media

Course Content

Developing a Diffuse Large B-Cell Lymphoma PET probe, including radiofluorination, in vitro and in vivo biological assessments

  • Abstract
    00:00
  • Developing a Diffuse Large B-Cell Lymphoma PET probe, including radiofluorination, in vitro and in vivo biological assessments
    00:00

Design and in vivo evaluation of an antibody-radio-drug conjugate (ArDC) for click-to-release conversion from a SPECT probe state to a cytotoxic state in a mouse lung cancer model

Evaluating the Pharmacokinetic Properties of 225Ac-labeled Macropa Chelators for Targeted Alpha Therapy in a DLL3-Expressing Small-Cell Lung Cancer Model

Targeting ALDH1A1 for the identification and treatment of therapy resistant cancers

[18F]F-AraG uptake in the vertebral bone marrow predicts survival in immunotherapy treated non-small cell lung cancer patients

Comparing total-body metabolic PET imaging signatures of lung cancer cachexia to other wasting conditions

ChoKα-targeted NIR fluorophore for intraoperative NSCLC imaging in clinical companion canines